Barton Cobert
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Antibiotics Pharmacokinetics and Efficacy
- Toxicology top 10%
Papers in
-
- Pharmacogenetics and Drug Metabolism 3
- Drug-Induced Hepatotoxicity and Protection 2
- Antibiotics Pharmacokinetics and Efficacy 2
- Pharmaceutical industry and healthcare 2
-
- Pharmacovigilance and Adverse Drug Reactions 4
- Co-authors
- Dominique Pessayre (5 shared papers)M. Alba Greco (1 shared paper)Roger Schinella (1 shared paper)Véronique Descatoire (3 shared papers)Jean‐Pierre Benhamou (2 shared papers)Daniel Mansuy (2 shared papers)Christian Funck‐Brentano (2 shared papers)Dominique Larrey (2 shared papers)
- Journals
- Biochemical Pharmacology (3 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Annals of Internal Medicine (1 paper)Drug Safety (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesFranceVietnam
In The Last Decade
Barton Cobert
14 papers receiving 508 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 259
- Toxicology 22
- Cell Biology 80
- Oncology 129
- Pharmacology 72
Countries citing papers authored by Barton Cobert
This map shows the geographic impact of Barton Cobert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barton Cobert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barton Cobert more than expected).
Fields of papers citing papers by Barton Cobert
This network shows the impact of papers produced by Barton Cobert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barton Cobert. The network helps show where Barton Cobert may publish in the future.
Co-authors
The 25 scholars most cited alongside Barton Cobert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1980 | 110 | |
| 2 | 1981 | 91 | |
| 3 | 1989 | 63 | |
| 4 | 1981 | 62 | |
| 5 | 1980 | 54 | |
| 6 | 1983 | 49 | |
| 7 | 1982 | 43 | |
| 8 | 1990 | 30 | |
| 9 | 1999 | 14 | |
| 10 | 1999 | 7 | |
| 11 | 1989 | 7 | |
| 12 | Drug Safety Data: How to Analyze, Summarize, and Interpret to Determine Risk | 2010 | 6 |
| 13 | Pharmacovigilance from A to Z : adverse drug event surveillance | 2002 | 5 |
| 14 | 2018 | 4 |
About Barton Cobert
Barton Cobert is a scholar working on Pharmacology, Toxicology, Oncology, Molecular Biology and Pharmacology, having authored 14 papers that have together received 545 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Pharmaceutical Quality and Counterfeiting (2 papers), Pharmaceutical industry and healthcare (2 papers) and Atherosclerosis and Cardiovascular Diseases (1 paper). The work is most often cited by research in Pharmacology (259 citations), Toxicology (22 citations), Cell Biology (80 citations), Oncology (129 citations) and Pharmacology (72 citations). Barton Cobert has collaborated with scholars based in United States, France and Vietnam. Frequent co-authors include Dominique Pessayre, M. Alba Greco, Roger Schinella, Véronique Descatoire, Jean‐Pierre Benhamou, Daniel Mansuy, Christian Funck‐Brentano, Dominique Larrey, G Babany and J. Catesby Ware. Their work appears in journals such as Biochemical Pharmacology, Journal of Pharmacology and Experimental Therapeutics, Annals of Internal Medicine, Drug Safety and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.